Overview

Articaine vs Dexmedetomidine Supplemented Articaine

Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block
Phase:
Early Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams University
Treatments:
Carticaine
Dexmedetomidine
Criteria
Inclusion Criteria:

- adult patient with chronic renal failure on hemodialysis scheduled for radiocephalic
fistula creation

Exclusion Criteria:

- Allergy to local anesthetics.

- Infection at the site of needle insertion.

- Those having international normalized ratio more than 1.5.

- Coagulopathy.

- Neuromuscular, or severe hepatic or severe pulmonary disease.

- Those having epilepsy.

- Patients who refused to participate.